NEW YORK, April 10, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Abbott Laboratories (NYSE: ABT), Humana Inc. (NYSE: HUM), United Technologies Corporation (NYSE: UTX), 3M Company (NYSE: MMM), and Ingersoll-Rand Plc (NYSE: IR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

--

Abbott Laboratories Analyst Notes

On April 1, 2014, Abbott Laboratories (Abbott) confirmed in a press release that it will announce its Q1 2014 financial results on April 16, 2014, before the market opens. As per the release, the announcement will be followed by a live webcast of the earnings conference call at 8:00 a.m. CT (9:00 a.m. ET), and will be accessible through Abbott's Investor Relations website. According to Zacks Investment Research data, the consensus EPS estimate for the quarter is $0.35. For Q4 2013, Abbott reported net earnings from continuing operations, excluding specified items, of $918 million or $0.58 per share, in line with the estimates of analysts polled by Thomson Reuters. For 2014, Abbott issued ongoing EPS guidance of $2.16 to $2.26, representing double-digit growth at the mid-point of the guidance range. The full analyst notes on Abbott Laboratories are available to download free of charge at:

http://www.AnalystsReview.com/04102014/ABT/report.pdf

--

Humana Inc. Analyst Notes

On April 2, 2014, Humana Inc. (Humana) has announced that Humana Cares / Senior Bridge, Humana's national chronic care management division is identifying and managing the 500 Humana Medicare Advantage members who will participate for a six-month duration pilot project called as "Activities of Daily Living." The project is aimed at helping members remain independently with the help of Pharos' patented technology platform, called Tel-Assurance. Participating members will report their health information themselves daily, such as blood sugar, symptoms, diet and medication adherence, using preferable modes of communication like a cellphone, telephone or the Internet. Tel-Assurance nurses will check the received member information and reach out to them if there are any areas of concern. The full analyst notes on Humana Inc. are available to download free of charge at:

http://www.AnalystsReview.com/04102014/HUM/report.pdf

--

United Technologies Corporation Analyst Notes

Shares in United Technologies Corporation (United Technologies) fell for the third consecutive session and closed at $116.18, witnessing a fall of 1.69% on April 7, 2014, over the previous day's close. The stock opened at $117.20 and traded in the range of $116.11 - $118.66 during the day. As much as 3.49 million shares were traded in the session. The stock scaled a new 52-week high of $120.49 on April 4, 2014. Over the past 12 months, the stock has gained an upside of 23.98%, outperforming the NYSE Composite which retuned 14.98% during the same time period. The full analyst notes on United Technologies Corporation are available to download free of charge at:

http://www.AnalystsReview.com/04102014/UTX/report.pdf

--

3M Company Analyst Notes

On April 3, 2014, 3M Company (3M) conducted a survey that highlighted the fact that libraries using both the 3M(TM) Cloud Library and OverDrive(R) are over twice as satisfied with the 3M Cloud Library as compared to OverDrive. The survey data revealed the difference these features make in librarians' satisfaction with their eBook systems. Krisa Drost, 3M Customer Experience Manager, said, "The Cloud Library was designed with input from librarians at every step. These satisfaction scores further validate our approach, and we are excited to continue developing our best-in-class system to make it easier than ever." The full analyst notes on 3M Company are available to download free of charge at:

http://www.AnalystsReview.com/04102014/MMM/report.pdf

--

Ingersoll-Rand Plc Analyst Notes

On April 3, 2014, Ingersoll-Rand Plc (Ingersoll Rand) announced that it will release its Q1 2014 financial results on April 23, 2014, at 7:00 a.m. ET. As per the Company website, Michael W. Lamach, Chairman and CEO, and Susan K. Carter, Senior VP and CFO, will hold a conference call for analysts and investors, to review the Company's financial results, on the same day, beginning at 10:00 a.m. ET. According to Zacks.com, the consensus EPS estimate for the quarter is $0.26. In a separate press release dated April 2, 2014, the Company announced a quarterly dividend of $0.25 per ordinary share payable June 30, 2014, to shareholders of record on June 13, 2014. The full analyst notes on Ingersoll-Rand Plc are available to download free of charge at:

http://www.AnalystsReview.com/04102014/IR/report.pdf

--

About Analysts Review We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

--

=============

EDITOR NOTES: 


        
        - This is not company news. We are an independent source and our views do
          not reflect the companies mentioned.
        - Information in this release is fact checked and produced on a best efforts
          basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human
          and are prone to make mistakes. If you notice any errors or omissions, please notify
          us below.
        - This information is submitted as a net-positive to companies mentioned, to
          increase awareness for mentioned companies to our subscriber base and the investing
          public.
        - If you wish to have your company covered in more detail by our team, or wish
          to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
        - For any urgent concerns or inquiries, please contact us at compliance [at]
          AnalystsReview.com.
        - Are you a public company? Would you like to see similar coverage on your
          company? Send us a full investors' package to research [at] AnalystsReview.com for
          consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA(R) and Chartered Financial Analyst(R) are registered trademarks owned by CFA Institute.

SOURCE Analysts Review